The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Public ClinicalTrials.gov record NCT03896958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The PIONEER Initiative: Precision Insights On N-of-1 Effectiveness Research. Tissue Ownership by the Individual With the Return of Actionable Information to the Individual Patient and Physician (Precision Oncology)
Study identification
- NCT ID
- NCT03896958
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- SpeciCare
- Industry
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
- Adenocarcinoma Lung
- Adrenal Cancer
- Breast Cancer
- Bronchoalveolar Cell Lung Cancer
- Cancer Cords Vocal
- Cancer Differentiated Poorly
- Cancer Skin
- Cancer Unknown Primary
- Cancer of Brain and Nervous System
- Cancer of Cervix
- Cancer of Colon
- Cancer of Esophagus
- Cancer of Head and Neck
- Cancer of Kidney
- Cancer of Larynx
- Cancer of Liver
- Cancer of Lung
- Cancer of Neck
- Cancer of Pancreas
- Cancer of Prostate
- Cancer of Rectum
- Cancer of Stomach
- Cancer of Vulva, Disseminated
- Cancer, Advanced
- Cancer, All Types
- Cancer, Anal
- Cancer, Anaplastic Thyroid
- Cancer, Bile Duct
- Cancer, Bladder
- Cancer, Metastatic
- Cancer, Other
- Cancers Cell Neuroendocrine
- Cholangiocarcinoma
- GIST
- Glioblastoma Multiforme
- Hepatocellular Carcinoma
- Melanoma
- Oligodendroglioma
- Renal Cell Carcinoma
- Sarcoma
- Small-cell Lung Cancer
- Squamous Cell Carcinoma
- Testicular Cancer
- Transitional Cell Carcinoma
- Uterine Cancer
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 1 Month to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 20, 2019
- Primary completion
- Mar 11, 2024
- Completion
- Mar 11, 2024
- Last update posted
- Dec 3, 2020
2019 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Specicare | Gainesville | Georgia | 30501 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03896958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2020 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03896958 live on ClinicalTrials.gov.